News Detail
New Delhi, 3 May 2023: AstraZeneca Pharma India Ltd., a science-led biopharmaceutical company, on wednesday announced that it has received approval from the Drugs Controller General of India (DCGI) for the cancer drug Trastuzumab Deruxtecan for the treatm......
View Details
View Details
Source : ANI
breast cancer
AstraZeneca
drug
cancer drug Trastuzumab Deruxtecan
Trastuzumab Deruxtecan
Daiichi Sankyo
drugscontrol
Related News
- DTAB recommends amendment of Rule 64 related to qualification of competent person (23-10-2024)
- Seven arrested for smuggling prescription medicines sourced from Kerala (23-10-2024)
- ANTF busted Fake medicines factory in Agra, medicines worth Rs 4.5 crore recovered (23-10-2024)
- Six of family killed in Oxygen cylinder blast in Bulandshahr (22-10-2024)
- Gujarat has two new and one upgraded drug testing lab in Surat, Rajkot and Vadodara (22-10-2024)
- Digital transformation of TN DCA increased efficiency: M Sridhar (22-10-2024)
- Oral Semaglutide shows cardio benefits in certain diabetes patients (22-10-2024)
- Waiver of testing requirement for Cough Syrup exports to USA, UK, Canada, EU, Japan, Australia, Singapore, Republic of Korea and Switzerland (22-10-2024)
- DTAB agrees with proposal to amend ND&CT Rules to ease registration process of Ethics Committees (21-10-2024)
- Stringent steps needed to keep India label safe from fly-by-night operators (21-10-2024)